Related references
Note: Only part of the references are listed.Vaccines based on novel adeno-associated virus vectors elicit aberrant CD8+ T-Cell responses in mice
Hanping Lin et al.
JOURNAL OF VIROLOGY (2007)
CD8+ T-cell responses to adeno-associated virus capsid in humans
Federico Mingozzi et al.
NATURE MEDICINE (2007)
Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice
CD Scallan et al.
BLOOD (2006)
Systemic protein delivery by muscle-gene transfer is limited by a local immune response
LX Wang et al.
BLOOD (2005)
Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy
LL Wang et al.
BLOOD (2005)
Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques
PR Johnson et al.
JOURNAL OF VIROLOGY (2005)
DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A*0201 mice
G Gallez-Hawkins et al.
VACCINE (2004)
Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain
CS Peden et al.
JOURNAL OF VIROLOGY (2004)
A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors
A Auricchio et al.
MOLECULAR THERAPY (2001)
Share Paper
